Vascular endothelial growth factor receptor 2 expression and immunotherapy efficacy in non–small cell lung cancer

It is unclear whether tumor vascular endothelial growth factor receptor 2 expression affects the therapeutic efficacy of immune‐checkpoint inhibitors and antiangiogenic agents. This retrospective, multicenter study included patients with advanced non–small cell lung cancer who were treated with immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakahama, Kenji, Kaneda, Hiroyasu, Osawa, Masahiko, Fukui, Mitsuru, Izumi, Motohiro, Yoshimoto, Naoki, Sugimoto, Akira, Nagamine, Hiroaki, Ogawa, Koichi, Matsumoto, Yoshiya, Sawa, Kenji, Tani, Yoko, Mitsuoka, Shigeki, Watanabe, Tetsuya, Asai, Kazuhisa, Kawaguchi, Tomoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459341/
https://www.ncbi.nlm.nih.gov/pubmed/35722982
http://dx.doi.org/10.1111/cas.15464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459341/
https://www.ncbi.nlm.nih.gov/pubmed/35722982
http://dx.doi.org/10.1111/cas.15464

Ejemplares similares